ArticleNeuro-oncology advances

Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.

Mahmoud S Alghamri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.